# EDGAR Filing Document

**Accession Number:** 0001792030
**File Stem:** 0001178913-23-001036
**Filing Date:** 2023-3
**Character Count:** 7432
**Document Hash:** bd28dbf550f40e676a733db46b702bec
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001178913-23-001036.hdr.sgml**: 20230317

**ACCESSION NUMBER**: 0001178913-23-001036

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230317

**FILED AS OF DATE**: 20230317

**DATE AS OF CHANGE**: 20230317

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** IM Cannabis Corp.
- **CENTRAL INDEX KEY:** 0001792030
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40065
- **FILM NUMBER:** 23740710

**BUSINESS ADDRESS:**
- **STREET 1:** 1 ADELAIDE STREET EAST, UNIT 801
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M5C 2V9
- **BUSINESS PHONE:** 416-256-4202

**MAIL ADDRESS:**
- **STREET 1:** 1 ADELAIDE STREET EAST, UNIT 801
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M5C 2V9

------

**UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION**<br> Washington, D.C. 20549<br>**Form 6-K**

<br> **REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16**<br> **UNDER THE SECURITIES EXCHANGE ACT OF 1934**

For the month of **<u>March 2023</u>**.

Commission File Number: **<u>001-40065</u>**

<br> <u>**IM Cannabis Corp.**</u><br> (Exact Name of Registrant as Specified in Charter)

<br> **<u>Kibbutz Glil Yam, Central District, Israel 4690500</u>**<br> (Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

**Note**: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

**Note**: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

------

#### SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **IM CANNABIS CORP.** | **IM CANNABIS CORP.** |
|  | (Registrant) | (Registrant) |
| Date: March 17, 2023 | By: | */s/ Oren Shuster* |
|  | Name: | Oren Shuster |
|  | Title: | Chief Executive Officer and Director |

---

------

#### EXHIBIT INDEX
[99.1](exhibit_99-1.htm) [Material Change Report dated March 17, 2023](exhibit_99-1.htm)

------

## Exhibit 99.1

------

<u>**Exhibit 99.1**</u><br>

#### <br>

#### FORM 51-102F3

#### MATERIAL CHANGE REPORT

#### Item 1 — Name and Address of Company
IM Cannabis Corp. (the "**Company**")<br> Suite 2300 – 550 Burrard Street

Vancouver, BC, Canada, V6C 2B5

#### Item 2 — Date of Material Change
The date of the material change was March 8, 2023.

#### Item 3 — News Release
The news release disclosing the material change was issued by the Company through the services of Canada Newswire on March 8, 2023 and subsequently filed on the Company's SEDAR profile at <u>www.sedar.com</u>.

#### Item 4 — Summary of Material Change
The Company announced a reorganization of its management and operations to strengthen its focus on core activities and drive efficiencies to realize sustainable profitability. To achieve this goal, the Company will be reducing its workforce in Israel by 20%-25% across all functions. All actions associated with the workforce reduction are expected to be substantially complete by mid-2023, subject to applicable Israeli law.

As part of the restructuring plan, key positions in the Company's global leadership team will be transitioned to highly skilled internal successors, who will be supported through a three-month transition period and a closely monitored handover process to ensure continuity. The Company expects to substantially complete the restructuring efforts during the first half of 2023.

#### Item 5 — Full Description of Material Change
5.1 – Full Description of Material Change

The Company announced a reorganization of its management and operations to strengthen its focus on core activities and drive efficiencies to realize sustainable profitability. To achieve this goal, the Company will be reducing its workforce in Israel by 20%-25% across all functions. All actions associated with the workforce reduction are expected to be substantially complete by mid-2023, subject to applicable Israeli law.

As part of the restructuring plan, key positions in the Company's global leadership team will be transitioned to highly skilled internal successors, who will be supported through a three-month transition period and a closely monitored handover process to ensure continuity.

Shai Shemesh, Chief Financial Officer of the Company, will be stepping down and handing over his responsibilities through a structured transition period to Itay Vago, who will be appointed as the Company's Chief Financial Officer. In his last role, Itay served as Finance Director of IMC Holdings Ltd., the Company's Israeli subsidiary ("**IMC Holdings**"). Itay is a skilled executive finance manager with more than 15 years of experience in multinational, publicly traded companies in the high-tech and pharmaceutical industries.

Rinat Efrima, Chief Executive Officer of IMC Holdings, will be stepping down and handing over her responsibilities through a structured transition period to Eyal Fisher, who will be appointed as the General Manager of IMC Holdings. In his last role, Eyal served as Sales Director of IMC Holdings. Eyal is an experienced senior manager in the retail and medical cannabis industries with extensive experience in sales, operations, and regulation.

Yael Harrosh, Chief Legal and Operations Officer of the Company, has been appointed to lead the Company's restructuring plan and will be stepping down from her current responsibilities through a structured transition period once a new General Counsel has been appointed.

The Company expects to substantially complete the restructuring efforts during the first half of 2023.

------

5.2 – Disclosure for Restructuring Transactions

Not applicable.

#### Item 6 — Reliance on subsection 7.1(2) of National Instrument 51-102
Not applicable.

#### Item 7 — Omitted Information
Not applicable.

#### Item 8 — Executive Officer
Yael Harrosh

Chief Legal and Operations Officer

+972-54-6687515

#### Item 9 — Date of Report
March 17, 2023

- 2 -<br>

------